This book explores the developments in the Indian pharmaceutical industry in the context of economic reforms introduced in India since 1991 and the implementation of the provisions in the TRIPS Agreement of the World Trade Organization. It also contains a comprehensive analysis of pharmaceutical export and import, research and development, access to medicines as well, as the latest drug price control system in the country.
This book looks at debates on global value chains (GVCs) and free trade agreements (FTAs) as springboards for industrial development in developing countries, especially India. It connects the outcomes in GVC-led industrial restructuring and upgrading to industrial policy choices in trade and FDI liberalisation, in particular those through FTAs.
This book explores the developments in the Indian pharmaceutical industry in the context of economic reforms introduced in India since 1991 and the implementation of the provisions in the TRIPS Agreement of the World Trade Organization. It also contains a comprehensive analysis of pharmaceutical export and import, research and development, access to medicines as well, as the latest drug price control system in the country.
This book looks at debates on global value chains (GVCs) and free trade agreements (FTAs) as springboards for industrial development in developing countries, especially India. It connects the outcomes in GVC-led industrial restructuring and upgrading to industrial policy choices in trade and FDI liberalisation, in particular those through FTAs.
Prenumerera på vårt nyhetsbrev för att få fantastiska erbjudanden och inspiration för din nästa läsning.
Genom att registrera dig accepterar du vår personuppgiftspolicy.
